Rare disease Group urges Trump Administration to Restore Clarity
01 Apr 2026 //
REUTERS
FDA warns of liver injury cases tied to Amgen`s Rare Disease Drug
01 Apr 2026 //
FDA
FDA is Expected to Lift Restriction on Certain Peptides
01 Apr 2026 //
NYTIMES
Biogen Bets on $5.6 Billion buyout of Apellis
01 Apr 2026 //
GLOBENEWSWIRE
Lilly seals up to $7.8B deal for Centessa in sleep Disorder
01 Apr 2026 //
PR NEWSWIRE
Drugmakers delay some European launches with a wary eye on Trump
01 Apr 2026 //
REUTERS
AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal
01 Apr 2026 //
FIERCE BIOTECH
Rusan Pharma Launches Parkinson Drug Aposan` in pre-filled Pen
01 Apr 2026 //
ECONOMICTIMES
Granules Life receives VAI Classification for Shamirpet facility
01 Apr 2026 //
PRESS RELEASE
Drugs In Development
Market Intel

Market Place
Sourcing Support